Financial giants have made a conspicuous bearish move on BridgeBio Pharma. Our analysis of options history for BridgeBio Pharma BBIO revealed 9 unusual trades.
Delving into the details, we found 33% of traders were bullish, while 66% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $198,225, and 6 were calls, valued at $926,400.
Predicted Price Range
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $10.0 to $50.0 for BridgeBio Pharma over the last 3 months.
Volume & Open Interest Development
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in BridgeBio Pharma's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to BridgeBio Pharma's substantial trades, within a strike price spectrum from $10.0 to $50.0 over the preceding 30 days.
BridgeBio Pharma 30-Day Option Volume & Interest Snapshot
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| BBIO | CALL | SWEEP | BEARISH | 01/17/25 | $10.00 | $266.4K | 30 | 766 |
| BBIO | CALL | TRADE | BEARISH | 01/17/25 | $10.00 | $240.0K | 30 | 175 |
| BBIO | CALL | SWEEP | BEARISH | 01/17/25 | $10.00 | $180.0K | 30 | 1.0K |
| BBIO | CALL | SWEEP | BEARISH | 01/17/25 | $10.00 | $120.0K | 30 | 925 |
| BBIO | PUT | SWEEP | BULLISH | 01/17/25 | $50.00 | $97.2K | 677 | 9 |
About BridgeBio Pharma
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy. The company focus on genetic diseases because they exist at the intersection of high unmet patient need and tractable biology.
Having examined the options trading patterns of BridgeBio Pharma, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
BridgeBio Pharma's Current Market Status
- With a trading volume of 361,134, the price of BBIO is up by 0.31%, reaching $32.51.
- Current RSI values indicate that the stock is may be overbought.
- Next earnings report is scheduled for 77 days from now.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for BridgeBio Pharma, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
